Richard Aldrich insider trades: Concert Pharmaceuticals (CNCE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC






and 7 more companies
Open-market buys and sales
82 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | CNCE | ↑ Buy | 210,526 | $4.75 | $1000K | By Richard H. Aldrich 2018 Revocable Tru | Jun 6, 2022 (0d) |
| Nov 15, 2018 | CNCE | ↑ Buy | 50,000 | $11.83 | $591K | Direct | Nov 15, 2018 (0d) |
| Feb 1, 2018 | CNCE | ↓ Sell | 11,946 | $20.89 | $250K | Indirect | Feb 1, 2018 (0d) |
| Jan 29, 2018 | CNCE | ↓ Sell | 18,054 | $20.63 | $372K | Indirect | Jan 29, 2018 (0d) |
| Jan 24, 2018 | CNCE | ↓ Sell | 30,000 | $19.68 | $591K | Indirect | Jan 24, 2018 (0d) |
| Jan 19, 2018 | CNCE | ↓ Sell | 30,000 | $19.35 | $580K | Indirect | Jan 19, 2018 (0d) |
| Jan 16, 2018 | CNCE | ↓ Sell | 21,236 | $19.08 | $405K | Direct | Jan 18, 2018 (2d) |
| Jan 16, 2018 | CNCE | ↓ Sell | 10,000 | $19.27 | $193K | Indirect | Jan 18, 2018 (2d) |
| Oct 12, 2017 | KALV | ↑ Buy | 565,065 | $8.61 | $4.9M | Indirect | Oct 19, 2017 (7d) |
| Jun 1, 2016 | OVAS | ↑ Buy | 425,000 | $7.00 | $3.0M | By Longwood Fund III LP | Jun 3, 2016 (2d) |
| May 18, 2016 | OVAS | ↑ Buy | 20,000 | $7.86 | $157K | By Longwood Fund III LP | May 20, 2016 (2d) |
| May 17, 2016 | OVAS | ↑ Buy | 40,000 | $7.63 | $305K | By Longwood Fund III LP | May 18, 2016 (1d) |
| May 13, 2016 | OVAS | ↑ Buy | 36,095 | $6.94 | $250K | By Longwood Fund III LP | May 16, 2016 (3d) |
| May 11, 2016 | OVAS | ↑ Buy | 20,000 | $7.64 | $153K | By Longwood Fund III LP | May 13, 2016 (2d) |
| May 10, 2016 | OVAS | ↑ Buy | 19,900 | $7.72 | $154K | By Longwood Fund III LP | May 12, 2016 (2d) |
| Mar 24, 2016 | OVAS | ↑ Buy | 59,800 | $9.49 | $567K | By Longwood Fund III LP | Mar 25, 2016 (1d) |
| Mar 22, 2016 | OVAS | ↑ Buy | 59,800 | $10.44 | $625K | By Longwood Fund III LP | Mar 23, 2016 (1d) |
| Mar 18, 2016 | OVAS | ↑ Buy | 59,700 | $8.26 | $493K | By Longwood Fund III LP | Mar 21, 2016 (3d) |
| Mar 16, 2016 | OVAS | ↑ Buy | 59,029 | $7.90 | $466K | By Longwood Fund III LP | Mar 17, 2016 (1d) |
| Mar 14, 2016 | OVAS | ↑ Buy | 162,732 | $7.60 | $1.2M | By Longwood Fund III LP | Mar 15, 2016 (1d) |
| Dec 16, 2015 | CNCE | ↓ Sell | 20,000 | $19.76 | $395K | Direct | Dec 17, 2015 (1d) |
| Jun 8, 2015 | PTCT | ↓ Sell | 7,000 | $55.66 | $390K | Direct | Jun 10, 2015 (2d) |
| Apr 8, 2015 | OVAS | ↑ Buy | 2,500 | $29.97 | $75K | By Richard H. Aldrich 2005 Revocable Tru | Apr 9, 2015 (1d) |
| Jul 7, 2014 | OVAS | ↑ Buy | 2,000 | $9.49 | $19K | By Richard H. Aldrich 2005 Revocable Tru | Jul 9, 2014 (2d) |
| Jun 30, 2014 | OVAS | ↑ Buy | 2,000 | $9.16 | $18K | By Richard H. Aldrich 2005 Revocable Tru | Jul 2, 2014 (2d) |
| Jun 23, 2014 | OVAS | ↑ Buy | 2,000 | $8.81 | $18K | By Richard H. Aldrich 2005 Revocable Tru | Jun 25, 2014 (2d) |
| Jun 16, 2014 | OVAS | ↑ Buy | 2,000 | $8.52 | $17K | By Richard H. Aldrich 2005 Revocable Tru | Jun 18, 2014 (2d) |
| Jun 9, 2014 | OVAS | ↑ Buy | 2,000 | $7.59 | $15K | By Richard H. Aldrich 2005 Revocable Tru | Jun 11, 2014 (2d) |
| Jun 2, 2014 | OVAS | ↑ Buy | 2,000 | $7.29 | $15K | By Richard H. Aldrich 2005 Revocable Tru | Jun 3, 2014 (1d) |
| May 27, 2014 | OVAS | ↑ Buy | 2,000 | $7.50 | $15K | By Richard H. Aldrich 2005 Revocable Tru | May 29, 2014 (2d) |
| May 20, 2014 | VSTM | ↑ Buy | 1,000 | $8.37 | $8K | Direct | May 21, 2014 (1d) |
| May 19, 2014 | OVAS | ↑ Buy | 2,000 | $7.33 | $15K | By Richard H. Aldrich 2005 Revocable Tru | May 21, 2014 (2d) |
| Mar 7, 2014 | OVAS | ↑ Buy | 100,000 | $10.00 | $1.0M | By Longwood Fund, LP | Mar 11, 2014 (4d) |
| Nov 11, 2013 | VSTM | ↑ Buy | 1,000 | $10.93 | $11K | By Richard H. Aldrich 2005 Revocable Tru | Nov 12, 2013 (1d) |
| Nov 4, 2013 | VSTM | ↑ Buy | 1,000 | $10.51 | $11K | By Richard H. Aldrich 2005 Revocable Tru | Nov 4, 2013 (0d) |
| Oct 28, 2013 | VSTM | ↑ Buy | 1,000 | $11.26 | $11K | By Richard H. Aldrich 2005 Revocable Tru | Oct 28, 2013 (0d) |
| Oct 21, 2013 | VSTM | ↑ Buy | 1,000 | $12.57 | $13K | By Richard H. Aldrich 2005 Revocable Tru | Oct 21, 2013 (0d) |
| Oct 14, 2013 | VSTM | ↑ Buy | 1,000 | $10.56 | $11K | By Richard H. Aldrich 2005 Revocable Tru | Oct 15, 2013 (1d) |
| Oct 7, 2013 | VSTM | ↑ Buy | 1,000 | $11.53 | $12K | By Richard H. Aldrich 2005 Revocable Tru | Oct 7, 2013 (0d) |
| Sep 30, 2013 | VSTM | ↑ Buy | 1,000 | $12.55 | $13K | By Richard H. Aldrich 2005 Revocable Tru | Sep 30, 2013 (0d) |
| Sep 23, 2013 | VSTM | ↑ Buy | 1,000 | $13.17 | $13K | By Richard H. Aldrich 2005 Revocable Tru | Sep 23, 2013 (0d) |
| Sep 16, 2013 | VSTM | ↑ Buy | 1,000 | $13.81 | $14K | By Richard H. Aldrich 2005 Revocable Tru | Sep 16, 2013 (0d) |
| Sep 11, 2013 | OVAS | ↑ Buy | 4,850 | $10.54 | $51K | by Richard H. Aldrich 2005 Revocable Tru | Sep 12, 2013 (1d) |
| Sep 9, 2013 | VSTM | ↑ Buy | 1,000 | $14.04 | $14K | By Richard H. Aldrich 2005 Revocable Tru | Sep 9, 2013 (0d) |
| Sep 3, 2013 | VSTM | ↑ Buy | 1,000 | $14.07 | $14K | By Richard H. Aldrich 2005 Revocable Tru | Sep 3, 2013 (0d) |
| Aug 26, 2013 | VSTM | ↑ Buy | 1,000 | $14.21 | $14K | By Richard H. Aldrich 2005 Revocable Tru | Aug 26, 2013 (0d) |
| Aug 19, 2013 | VSTM | ↑ Buy | 1,000 | $13.45 | $13K | By Richard H. Aldrich 2005 Revocable Tru | Aug 19, 2013 (0d) |
| Aug 12, 2013 | VSTM | ↑ Buy | 1,000 | $14.75 | $15K | By Richard H. Aldrich 2005 Revocable Tru | Aug 12, 2013 (0d) |
| Aug 5, 2013 | VSTM | ↑ Buy | 1,000 | $15.25 | $15K | By Richard H. Aldrich 2005 Revocable Tru | Aug 5, 2013 (0d) |
| Jul 29, 2013 | VSTM | ↑ Buy | 1,000 | $15.15 | $15K | By Richard H. Aldrich 2005 Revocable Tru | Jul 29, 2013 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Richard Aldrich's insider trades
Richard Aldrich is a director at Concert Pharmaceuticals (CNCE). Since Dec 21, 2006, Richard has reported 70 open-market purchases worth $45.0M and 12 sales worth $6.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (42 filings), conversions (5 filings), other transactions (4 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.